Browsing by Author "Artiko, Vera (55887737000)"
Now showing 1 - 20 of 42
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication 18F-fluorodeoxyglucose positron emission tomography / computed tomography in the diagnosis of secondary malignancies in a patient with Hodgkin lymphoma(2025) ;Pantić, Nikola (57221630977) ;Stojiljković, Milica (55217486100) ;Grujičić, Lenka (59909503300) ;Šaranović, Dragana Šobić (57234390300)Artiko, Vera (55887737000)Introduction The incidence of a second cancer among patients who have been treated for Hodgkin lymphoma (HL) is higher than the incidence of cancer in the general population.18F-fluorodeoxyglucose (18F-FDG) positron emission tomography / computed tomography is used in the evaluation of a number of malignancies. The aim of the article is to emphasize the importance of including a second primary cancer as a differential diagnosis among patients at risk. Case outline We present a case of a patient diagnosed with two separate malignancies almost two decades after the treatment of HL. Conclusion In patients previously treated for HL, a biopsy of lesions that show high 18F-FDG uptake should be advised, particularly if the location of the lesion is unusual for the primary diagnosis. © 2025, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Can 18F-FDG PET/CT scan change treatment planning and be prognostic in recurrent colorectal carcinoma? A prospective and follow-up study(2015) ;Artiko, Vera (55887737000) ;Odalovic, Strahinja (57218390032) ;Sobic-Saranovic, Dragana (57202567582) ;Petrovic, Milorad (55989504900) ;Stojiljkovic, Milica (55217486100) ;Petrovic, Nebojsa (7006674561) ;Kozarevic, Nebojsa (6507691500) ;Grozdic-Milojevic, Isidora (37107616900)Obradovic, Vladimir (7003389726)Objective: To prospectively study whether in patients with resected primary colorectal cancer fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) examination could diagnose the stage, specify treatment procedure and be prognostic. Subjects and methods: This prospective study included 75 patients with resected primary colorectal adenocarcinoma referred for 18F-FDG PET/CT to the National PET Center, at the Clinical Center of Serbia, Belgrade, from January 2010 to May 2013. Findings of 18F-FDG PET/CT were compared to findings of subsequent histopathological examinations or with results of clinical and imaging follow-up. Patients were followed after PET/CT examination for a mean follow-up time of 16.7±5.9 months. Results: In the detection of recurrent disease 18FFDG PET/CT showed overall sensitivity, specificity, PPV, NPV and accuracy of 96.6%, 82.4%, 94.9%, 87.5% and 93.3%, respectively. In the detection of stages I and II sensitivity, specificity and accuracy of 18F-FDG PET/CT were: 88%, 96.6% and 94.7%, respectively, and in the detection of stages III and IV sensitivity, specificity and accuracy were 94.9%, 87.5% and 93.3%, respectively. These findings prevented or changed intended surgical treatment in 12/32 cases. Univariate and multivariate Cox proportional regression analyses revealed that metastatic recurrence (stages III and IV) was the only and independent prognostic factor of disease progression during follow-up (P=0.012 and P=0.023, respectively). Although, survival seemed better in patients with local recurrence compared to metastatic recurrent disease, this difference did not reach significance (Log-rank test; P=0.324). In addition, progression-free survival time was significantly longer in patients in whom 18F-FDG PET/CT scan led to treatment changes (Log-rank test; P=0.037). Conclusion: 18F-FDG PET/CT was sensitive and accurate for the detection and staging of local and metastatic recurrent colorectal carcinoma, with higher specificity in the detection of local recurrences. The 18F-FDG PET/CT scan induced treatment changes in 30/75 patients, including 12/32 patients in which surgical treatment was previously planned, and progression free survival time was significantly longer in these patients. - Some of the metrics are blocked by yourconsent settings
Publication Clinical outcome of early glottic carcinoma in Serbia(2013) ;Milovanovic, Jovica (6603250148) ;Djukic, Vojko (6701658274) ;Milovanovic, Aleksandar (22035600800) ;Jotic, Ana (35173257500) ;Banko, Bojan (35809871900) ;Jesic, Snezana (6603837859) ;Babic, Borivoj (25121401500) ;Trivic, Aleksandar (8301162500) ;Artiko, Vera (55887737000) ;Petrovic, Milorad (55989504900)Stankovic, Predrag (8301161500)Objective: Proposed methods for treating early glottic carcinoma are cordectomy through laryngofissure, laser cordectomy, and radiotherapy. The aim of the study was to conduct comprehensive study to evaluate oncological and functional results of different treatment modalities for Tis and T1 glottic carcinoma, identify prognostic factors for the outcome of treatment and decide where we stand in applying worldwide standards of early glottic carcinoma treatment. Methods: Prospective study was conducted on 221 patients treated with Tis and T1 glottic carcinoma from 1998 to 2003 (72 patients were treated endoscopically with CO2 laser, 75 patients with cordectomy through laryngofissure and 74 with radiotherapy), with follow-up period from 38 to 107 months. Important demographic and clinical variables were analyzed. Voice quality after the treatment was assessed using multidimensional voice analysis. Results: Comparing oncological results of three modalities of treatment, there were no significant differences. Functional results of treatment were better after laser cordectomy and primary radiotherapy than following the open cordectomy. Five-year survival rate was almost identical in all three groups of patients, and important prognostic factors for survival were age and histological grade of the tumor. Conclusion: Considering that the choice of treatment in our country is also greatly influenced by other paramedical factors, such as distance from treatment facility, reliability of follow-up, significant time delay of radiotherapy because of small number of radiology centers and strong patients' surgeon and treatment preference, we consider endoscopic laser surgery highly efficient and preferred choice of treatment for early glottic carcinoma. © 2012 Elsevier Ireland Ltd. - Some of the metrics are blocked by yourconsent settings
Publication Clinical relevance of 18F-FDG PET/CT in the postoperative follow-up of patients with history of medullary thyroid cancer(2020) ;Saponjski, Jelena (57207943674) ;Macut, Djuro (35557111400) ;Saranovic, Dragana Sobic (57202567582) ;Radovic, Branislava (57189356247)Artiko, Vera (55887737000)The aim of the study was evaluation of 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography with computed tomography (PET/CT) in the detection of active disease in the patients with suspected recurrence of the medullary thyroid carcinoma (MTC). 18F-FDG PET/CT investigation was performed in 67 patients, investigated from 2010 to 2019. _ Follow up was performed from 6 to 116 months after surgery (median 16.5 months, x± SD = 29±28.9 months). Twenty five of 67 patients underwent 99mTc-dimercaptosuccinic acid (99mTc-DMSA) scintigraphy, 11 underwent somatostatin receptor scintigraphy (SRS) with 99mTc-HYNIC TOC while 11 123I-metaiodobenzylguanidine (MIBG) scintigraphy. From 67 patients, 35 (52.2%) had true positive 18F-FDG PET/CT findings (TP). Average maximal standardized uptake value (SUVmax) for all TP lesions was 5.01+3.6. In 25 (37.3%) patients findings were true negative (TN). Four (6%) patients had false positive (FP) findings while three (4.5%) were false negative (FN). Thus, sensitivity of the 18F-FDG PET/ CT was 92.11%, specificity 86.21%, positive predictive value 89.74%, negative predictive value 89.29% and accuracy 89.55%. In 27 patients (40%) 18F-FDG PET/CT finding influenced further management of the patient. 18F-FDG PET/CT has high accuracy in the detection of metastases/recurrences of MTC in patients after thyroidectomy as well as in evaluation and the appropriate choice of the therapy. © 2021 2021 Jelena Saponjski, Djuro Macut, Dragana Sobic Saranovic, Branislava Radovic, Vera Artiko, published by Sciendo. - Some of the metrics are blocked by yourconsent settings
Publication Clinical value of immunoscintigraphy in the rectal carcinomas: Immunoscintigraphy of rectal carcinomas(2013) ;Petrović, Milorad (55989504900) ;Janković, Z. (56216490800) ;Jauković, Lj. (12769289900) ;Artiko, Vera (55887737000) ;Šobic-Šaranovic, Dragana (57202567582) ;Antić, Andrija (6603457520) ;Žuvela, Marinko (6602952252) ;Radovanović, Nebojša (57221820776) ;Palibrk, Ivan (6507415211) ;Galun, Danijel (23496063400) ;Matić, Slavko (7004660212) ;Lončar, Zlatibor (26426476500) ;Bojović, Predrag (29367568800) ;Ajdinovic, Boris (24167888800)Obradovic, Vladimir (7003389726)Background/Aim: The aim of this study was to evaluate the clinical reliability of the immunoscintigraphy with radiolabeled monoclonal antibodies for the detection of metastases and recurrences of rectal carcinomas. Methodology: A total of 65 patients underwent immunoscintigraphy with radiolabeled monoclonal antibodies. Indication for that examination was suspicious rectal cancer or suspicious rectal cancer recurrence and/or metastases. Results: The method proved to have 92.7% sensitivity, specificity 83.3%, positive predictive value 90.5%, negative predictive value 87.0% and accuracy 89.2%. There was a statistically significant relationship between immunoscintigraphy findings and rectoscopy findings (rs=0.415, p=0.013), as well as significant relationship between immunoscintigraphy findings and US findings (rs=0.332, p=0.001). Tumor marker levels were in positive correlation with findings of immunoscintigraphy (r s=0.845, p=0.001), especially raised CEA level (rs=0.816, p=0.004). Patients with higher CA19-9 level had higher Duke's stage (p=0.025). Conclusions: We can conclude that immunoscintigraphy can be helpful in the detection of metastases and recurrences of colon carcinomas. © H.G.E. Update Medical Publishing S.A. - Some of the metrics are blocked by yourconsent settings
Publication Contemporary nuclear medicine diagnostics of neuroendocrine tumors(2015) ;Todorović-Tirnanić, Mila (12772684600) ;Artiko, Vera (55887737000) ;Pavlović, Smiljana (57225355345) ;Šobić-Šaranović, Dragana (57202567582)Obradović, Vladimir (7003389726)The new positron emission tomography (PET/CT) methods for neuroendocrine tumors detection are presented and compared with classic, conventional methods. Conventional methods use a gamma scintillation camera for patients with neuroendocrine tumor imaging, after intravenous injection of one of the following radiopharmaceuticals: 1) somatostatin analogues labeled with indium-111 (111In-pentetreotide) or technetium-99m (99mTc-EDDA/HYNIC-TOC); 2) noradrenaline analogue labeled with iodine-131 or -123 (131I/123I-MIBG); or 3)99mTc(V)-DMSA. Contemporary methods use PET/CT equipment for patients with neuroendocrine tumor imaging, after intravenous injection of pharmaceuticals labeled with positron emitters [fluorine-18 (18F), galium-68 (68Ga), or carbon-11 (11C)]: 1) glucose analogue (18FDG); 2) somatostatin analogue (68Ga-DOTATOC/68Ga-DOTATATE/68Ga-DOTANOC); 3) aminoacid precursors of bioamines: [a) dopamine precursor18F-DOPA (6-18F-dihydroxyphenylalanine), b) serotonin precursor11C-5HTP (11C-5-hydroxytryptophan)]; or 4) dopamine analogue 18F-DA (6-18F-fluorodopamine). Conventional and contemporary (PET/ CT) somatostatin receptor detection showed identical high specificity (92%), but conventional had very low sensitivity (52%) compared to PET/CT (97%). It means that almost every second neuroendocrine tumor detected by contemporary method cannot be discovered using conventional (classic) method. In metastatic pheochromocytoma detection contemporary (PET/ CT) methods (18F-DOPA and18F-DA) have higher sensitivity than conventional (131I/123I-MIBG). In medullary thyroid carcinoma diagnostics contemporary method (18F-DOPA) is more sensitive than conventional 99mTc(V)-DMSA method, and is similar to 18FDG, computed tomography and magnetic resonance. In carcinoid detection contemporary method (18F-DOPA) shows similar results with contemporary somatostatin receptor detection, while for gastroenteropancreatic neuroendocrine tumors it is worse. To conclude, contemporary (PET/CT) methods for somatostatin receptor detection (68Ga-DOTATOC/-NOC/-TATE) in neuroendocrine tumors are much more sensitive (almost twice) and more accurate than conventional. Therefore the classical methods should be urgently replaced by contemporary methods. - Some of the metrics are blocked by yourconsent settings
Publication Correlation between myocardial perfusion imaging findings and future cardiac events in patients with type 2 diabetes mellitus(2021) ;Stanković, Siniša (57191280985) ;Šobić-šaranović, Dragana (57202567582) ;Soldat-Stanković, Valentina (57058691700) ;Artiko, Vera (55887737000) ;Rajkovača, Zvezdana (23994099200) ;Mikač, Gostimir (57371626000) ;Egeljić-Mihailović, Nataša (57300235500)Majkić, Marina (57371391800)Introduction/Objective Myocardial perfusion imaging (MPI) is clinically useful for the evaluation of coronary artery disease in patients with diabetes mellitus. However, the prevalence of ischemia and its ability to predict future cardiac events is less clear. The aim was to determine the incidence of cardiac events in diabetic patients and the relationship between them and MPI findings. Methods Two cohorts of patients, 98 diabetics and 100 non-diabetics, with medium-to high-risk of coronary artery disease without previous coronary revascularization, were studied prospectively. All of them were outpatients who underwent99mTc-sestamibi MPI with dipyridamole. The data about cardiac events were collected during a follow-up period of two years. Results Cardiac events occurred in 17.3% diabetics and in 8% non-diabetics (p = 0.048). Diabetics had shorter estimated event-free time of 24.7 months (95% CI 23.2–26.2) versus non-diabetics’ estimated event-free time of 28.5 months (95% CI 27.4–29.5) (p = 0.046). The independent predictors of cardiac events were male sex (p = 0.010), previous myocardial infarction (p < 0.001), presence of the symptoms of angina (p = 0.014), and all variables derived from MPI findings. After adjustment for variables derived from MPI findings, the significant predictors in diabetics were the size of stress perfusion defect (p = 0.022), summed stress score (p = 0.011), and summed difference score (p = 0.044). Conclusion In diabetic patients, the cumulative rate of cardiac events was higher and the event-free survival was worse. MPI could help in prediction of cardiac events in diabetics and the most important predictors were size of stress perfusion defect, summed stress score, and summed difference score. © 2021, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis of mesh infection after abdominal wall hernia surgery - Role of radionuclide methods(2011) ;Žuvela, Marinko (6602952252) ;Antic, Andrija (6603457520) ;Bajec, Djordje (6507000330) ;Radenkovic, Dejan (6603592685) ;Petrovic, Milorad (55989504900) ;Galun, Danijel (23496063400) ;Palibrk, Ivan (6507415211) ;Duric, Aleksandra (57211128674) ;Kaznatovic, Zoran (54681975000) ;Banko, Bojan (35809871900) ;Milovanovic, Jovica (6603250148) ;Milovanovic, Aleksandar (57213394853) ;Sǎranovic, Dordije (57190117313) ;Artiko, Vera (55887737000) ;Sǒbic, Dragana (57202567582)Obradovic, Vladimir (7003389726)Background/Aims: The aim of this investigation was to evaluate the role of detection of late mesh infection following incisional hernia repair with radiolabeled antigranulocyte antibodies. Methodology: Mesh infection diagnoses were set up with clinical examination and laboratory analysis and confirmed by ultrasonography (US), computerized tomography (CT), scintigraphy with 99mTc-antigranulocyte antibodies and microbiological examination. Results: Of the 17 patients investigated, 6 had a late mesh infection, and 11 had both mesh infection and recurrent incisional hernia. Clear clinical signs of late mesh infection were present in 13 patients. Four remaining patients had non-specific discomfort and recurrent incisional hernia without clinical manifestation of mesh infection ("silent infection"). US was positive in 12/17 patients, CT in 13/17 patients, while scintigraphy with antigranulocyte antibodies in 17/17 patients. Therefore, sensitivity of US was 71%, of CT 76% and of scintigraphy 100%. In four patients late mesh infection was confirmed exclusively by 99mTc-antigranulocyte antibody scintigraphy, while US and CT did not indicate the infection. Conclusions: According to the present results, scintigraphy with 99mTc antigranulocyte antibodies is a useful method for the detection of "silent" abdominal wall infections after surgery, which is very important for prompt and appropriate therapy. © H.G.E. Update Medical Publishing S.A. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis of Raynaud’s phenomenon by 99mTc-pertechnetate hand perfusion scintigraphy: a pilot study(2016) ;Pavlov-Dolijanovic, Slavica (8452470400) ;Petrovic, Nebojsa (7006674561) ;Vujasinovic Stupar, Nada (24831218300) ;Damjanov, Nemanja (8503557800) ;Radunovic, Goran (13402761800) ;Babic, Dragan (56197715200) ;Sobic-Saranovic, Dragana (57202567582)Artiko, Vera (55887737000)We assess the usefulness of 99mTc-pertechnetate hand perfusion scintigraphy in patients with Raynaud’s phenomenon (RP). The study population consisted of 18 patients with primary RP, 25 patients with secondary RP within systemic sclerosis (SSc), and ten healthy individuals. Gamma camera dynamic first-pass study during the first 60 s and a static scintigraphy after 5 min were recorded following a bolus injection of 99mTc-pertechnetate via a cubital vein. Regions of interest were drawn on the summed images around the fingers and the palmar region. The fingers-to-palm ratios were then calculated. The mean fingers-to-palm ratio for dynamic study (blood flow) was 0.58 ± 0.19 for the healthy group, 0.45 ± 0.18 for the primary RP, and 0.43 ± 0.21 for the SSc patients. The mean fingers-to-palm ratio for static study (blood pool) was 0.44 ± 0.06 for the healthy group, 0.42 ± 0.06 for the primary RP, and 0.36 ± 0.07 for the SSc patients. Analysis of variance showed these differences to be significant (p = 0.039 from blood flow and p = 0.004 from blood pool). The receiver operating characteristic curve showed sensitivity of 80% and a specificity of 60% when using cutoff values of 0.40 for blood flow and sensitivity of 79% and a specificity of 70% when using cutoff values of 0.37 for blood pool. Our method is able to differentiate between patients with normal and those with abnormal microcirculation of the hands. Dynamic study separates the healthy subjects from patients with RP, while static study separates primary from secondary RP. © 2016, Springer-Verlag Berlin Heidelberg. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis of Raynaud’s phenomenon by 99mTc-pertechnetate hand perfusion scintigraphy: a pilot study(2016) ;Pavlov-Dolijanovic, Slavica (8452470400) ;Petrovic, Nebojsa (7006674561) ;Vujasinovic Stupar, Nada (24831218300) ;Damjanov, Nemanja (8503557800) ;Radunovic, Goran (13402761800) ;Babic, Dragan (56197715200) ;Sobic-Saranovic, Dragana (57202567582)Artiko, Vera (55887737000)We assess the usefulness of 99mTc-pertechnetate hand perfusion scintigraphy in patients with Raynaud’s phenomenon (RP). The study population consisted of 18 patients with primary RP, 25 patients with secondary RP within systemic sclerosis (SSc), and ten healthy individuals. Gamma camera dynamic first-pass study during the first 60 s and a static scintigraphy after 5 min were recorded following a bolus injection of 99mTc-pertechnetate via a cubital vein. Regions of interest were drawn on the summed images around the fingers and the palmar region. The fingers-to-palm ratios were then calculated. The mean fingers-to-palm ratio for dynamic study (blood flow) was 0.58 ± 0.19 for the healthy group, 0.45 ± 0.18 for the primary RP, and 0.43 ± 0.21 for the SSc patients. The mean fingers-to-palm ratio for static study (blood pool) was 0.44 ± 0.06 for the healthy group, 0.42 ± 0.06 for the primary RP, and 0.36 ± 0.07 for the SSc patients. Analysis of variance showed these differences to be significant (p = 0.039 from blood flow and p = 0.004 from blood pool). The receiver operating characteristic curve showed sensitivity of 80% and a specificity of 60% when using cutoff values of 0.40 for blood flow and sensitivity of 79% and a specificity of 70% when using cutoff values of 0.37 for blood pool. Our method is able to differentiate between patients with normal and those with abnormal microcirculation of the hands. Dynamic study separates the healthy subjects from patients with RP, while static study separates primary from secondary RP. © 2016, Springer-Verlag Berlin Heidelberg. - Some of the metrics are blocked by yourconsent settings
Publication Diagnostic and prognostic value of gated spect mibi early post-stress imaging in patients with intermediate duke treadmill score(2013) ;Sobic-Saranovic, Dragana P. (57202567582) ;Bojic, Ljiljana (41860988800) ;Petrasinovic, Zorica (56057995200) ;Grozdic-Milojevic, Isidora T. (37107616900) ;Pavlovic, Smiljana (57225355345) ;Artiko, Vera (55887737000) ;Jaksic, Emilija (6507797044) ;Obradovic, Vladimir (7003389726)Dondi, Maurizio (56789705600)Purpose of the Report: The aims of this study were to compare perfusion and functional parameters between early (ES) and standard (SS) post-stress gated SPECT MIBI, to validate ES against coronary angiography, and to determine whether ES parameters can predict future cardiac events. Patients and Methods: The sample included 63 patients with normal or mildly impaired left ventricular function and intermediate Duke Treadmill Score. They underwent a 2-day stress-rest gated SPECT MIBI with the poststress data acquired at 15 minutes (ES) and 60 minutes (SS) after i.v. injection of 740 MBq of 99mTc-MIBI. The ES findings were compared to SS and against coronary angiography to determine their sensitivity/specificity for detecting 970% stenosis. The information about new-onset cardiac events was collected 26 T 6 months later. Results: Perfusion parameters did not significantly differ between ES and SS. Ejection fraction was significantly lower and regional wall motion abnormalities were significantly higher on ES than SS. The corresponding perfusion and functional parameters were strongly related (linear regression slope 0.65-1.00, intercept j0.36Y8.5, R2 0.98Y0.75). ES parameters had high sensitivity (96%) and specificity (83%) for detecting 970% stenosis. Lower early stress than rest EF (95%), higher early stress than rest EDV, and early SSS 98 emerged as significant predictors of new-onset cardiac events. Conclusions: Early post-stress gated SPECT MIBI yields comparable perfusion and functional parameters as the standard post-stress protocol. ES parameters are useful for detecting the existing coronary disease and for predicting future cardiac events. ES protocol is recommended for improving patient compliance and efficiency of nuclear cardiology services. - Some of the metrics are blocked by yourconsent settings
Publication Diagnostic role and prognostic impact of positron emission tomography/computed tomography in patients treated for uterine corpus cancer(2024) ;Stojiljković, Milica (55217486100) ;Šobić-šaranović, Dragana (57202567582) ;Odalović, Strahinja (57218390032) ;Petrović, Jelena (57207943674) ;Popović-Krneta, Marina (57428070900) ;Veljković, Miloš (57211281286) ;Ranković, Nevana (57222052968)Artiko, Vera (55887737000)Introduction/Objective The goal of our research was to evaluate diagnostic and prognostic role of positron emission tomography/computed tomography (PET-CT) in patients previously treated for uterine cancer and compare it to conventional imaging methods (CIM). Methods We analyzed 37 patients examined on PET-CT for follow-up or suspicion of uterine cancer recurrence, and who were previously treated with surgery and/or chemoradiotherapy. All patients underwent CT or magnetic resonance imaging prior to PET-CT, and were followed-up for at least one year. Results PET-CT showed sensitivity, specificity and diagnostic accuracy in uterine cancer relapse detection of 96.3%, 70%, and 89.2%, while those values for CIM were 92.6%, 40%, and 78.4 %, respectively. Correlation of PET-CT and CIM findings was 78% (29/37). In 13 out of 25 true positive patients on CIM, PET-CT found greater number of active sites missed by conventional imaging. Positive findings on PET-CT were associated with shorter progression free survival (p = 0.023, logrank test). Conclusion PET-CT constitutes an important diagnostic method in management of recurrent cancer of uterine corpus, demonstrating high sensitivity and accuracy. In comparison to CIM, PET-CT can discover larger number of active tumor sites, and also shows better specificity. PET-CT positive patients have worse prognosis with shorter progression free survival. © 2024, Serbia Medical Society. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Diagnostic role of initial renal cortical scintigraphy in children with the first episode of acute pyelonephritis(2011) ;Jaksic, Emilija (6507797044) ;Bogdanovic, Radovan (7004665744) ;Artiko, Vera (55887737000) ;Saranovic, Dragana Sobic (57202567582) ;Petrasinovic, Zorica (56057995200) ;Petrovic, Milorad (55989504900) ;Bojic, Ljiljana (41860988800) ;Pavlovic, Smiljana (57225355345) ;Paripovic, Aleksandra (35311948800) ;Antonovic, Olga (25121054800) ;Lezaic, Visnja D. (55904881900) ;Saranovic, Djordjije (57217645313) ;Petrovic, Nebojsa (7006674561)Obradovic, Vladimir (7003389726)Objective: Assessment of the first febrile urinary tract infection (UTI) in children has been the subject of debate for many years. Diagnosis of acute pyelonephritis (APN) is usually based on clinical and biological data. The clinical usefulness of early Tc-99m DMSA scintigraphy remains controversial, although it may influence the type and duration of treatment. The aim of this study was to assess the role of initial cortical scintigraphy in the detection of early renal parenchymal damage in children highly suspected of having APN and to compare the scintigraphic findings with selected clinical/laboratory parameters and ultrasonography. Methods: A prospective study was conducted in 34 infants and young children (18 boys, 16 girls), aged 1.5-36 months (mean 9.8 ± 8.7 months), hospitalized with a first episode of clinically suspected APN. Within the first 5 days after admission, Tc-99m DMSA renal scintigraphy, ultrasonography (US), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), white blood cell count (WBC) and urine analyses were performed. Results: DMSA scintigraphy showed changes consistent with APN in 27/34 (79%) patients, with a mean age of 10.9 months, including 12 males (44%) and 15 (56%) females. Out of 9 febrile children with negative urine culture and supportive evidence of UTI, scintigraphy showed parenchymal involvement in 8 children (24% in the whole group, 30% in scintigraphically documented APN). There were no statistically significant correlations between the frequency or size of the initial scintigraphic abnormalities and age, sex, body temperature, CRP levels or ESR. A CRP level of >54 mg/L and a WBC of >13,300/mm3 had sensitivities of 56 and 59% and specificities of 86 and 71%, respectively. US showed changes consistent with APN in 7/34 (21%) in the whole group and in 7/27 (26%) patients with positive cortical scan (p < 0.05). Conclusion: Initial DMSA renal scintigraphy is a sensitive method for the early diagnosis of APN in young children and is useful in the assessment of the severity of kidney injury even in patients with negative urine culture. Clinical, biological and ultrasound parameters do not identify children with renal damage. Normal DMSA study, excluding parenchymal involvement and late sequelae, could minimize the use of scintigraphy in the follow-up and reduce the redundancy of cystography. © 2010 The Japanese Society of Nuclear Medicine. - Some of the metrics are blocked by yourconsent settings
Publication Diagnostic significance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors(2011) ;Banko, Bojan (35809871900) ;Crossed D Signukić, Vojko (54383104500) ;Milovanović, Jovica (6603250148) ;Kovač, Jelena Dokić (52563972900) ;Artiko, Vera (55887737000)Maksimović, Ružica (55921156500)To evaluate the diagnostic accuracy of pretreatment surgical magnetic resonance images (MRI) in the assessment of patients with laryngeal tumors. The prospective study included 34 patients (mean age 62.2 ± 5.1 years) with suspected tumors of the larynx who underwent laryngeal endoscopy, followed by MRI. The MRI images were evaluated for the invasion of anterior commissure, subglottis, paraglottic and preepiglotic space, cartilage invasion, extension to extralaryngeal tissue and lymph nodes, and were compared to pathological examination of surgical specimen. In 15 patients (44%) the tumor was glottic, in 10 patients (29%) supraglottic, in 9 (27%) patients tumor was transglottic. No statistical difference was seen in the number of patients with positive MRI findings in comparison to postsurgical pathohistology for extension to subglottic subside (29 vs. 38%), growth to the anterior commissure (48 vs. 48%), preepiglottic space (33 vs. 29%), and cartilage infiltration (19 vs. 14%), respectively. However, infiltration of the paraglottic spaces was observed more frequently on MRI (71 vs. 47%), p < 0.05. According to MR findings, 4 (12%) patients were classified as T2, 26 (76%) patients as T3 and 4 (12%) patients as T4, while on pathohystological specimens after surgery, 12 patients were classified as T2 (35%), 18 as T3 (53%), and 4 as T4 (12%). Based on MRI, 76% of the patients were correctly classified, which was shown to be statistically significant (ρ = 0.56, <0.05). Fifteen patients had metastases in regional lymph nodes and only two were detected on MRI. MRI has been shown to be a method that contributes to presurgical assessment of patients with tumor of the larynx. © 2011 Springer-Verlag. - Some of the metrics are blocked by yourconsent settings
Publication EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases(2021) ;Aarntzen, Erik H. J. G. (9235810800) ;Noriega-Álvarez, Edel (56938710100) ;Artiko, Vera (55887737000) ;Dias, André H. (56973358500) ;Gheysens, Olivier (9133013300) ;Glaudemans, Andor W. J. M. (57202217856) ;Lauri, Chiara (37034316500) ;Treglia, Giorgio (23669174700) ;van den Wyngaert, Tim (14319443800) ;van Leeuwen, Fijs W. B. (24447590700)Terry, Samantha Y. A. (55929844900)Inflammatory musculoskeletal diseases represent a group of chronic and disabling conditions that evolve from a complex interplay between genetic and environmental factors that cause perturbations in innate and adaptive immune responses. Understanding the pathogenesis of inflammatory musculoskeletal diseases is, to a large extent, derived from preclinical and basic research experiments. In vivo molecular imaging enables us to study molecular targets and to measure biochemical processes non-invasively and longitudinally, providing information on disease processes and potential therapeutic strategies, e.g. efficacy of novel therapeutic interventions, which is of complementary value next to ex vivo (post mortem) histopathological analysis and molecular assays. Remarkably, the large body of preclinical imaging studies in inflammatory musculoskeletal disease is in contrast with the limited reports on molecular imaging in clinical practice and clinical guidelines. Therefore, in this EANM-endorsed position paper, we performed a systematic review of the preclinical studies in inflammatory musculoskeletal diseases that involve radionuclide imaging, with a detailed description of the animal models used. From these reflections, we provide recommendations on what future studies in this field should encompass to facilitate a greater impact of radionuclide imaging techniques on the translation to clinical settings. © 2021, The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Estimation of infarct size using transthoracic Doppler echocardiographic measurement of coronary flow reserve in infarct related and reference coronary artery(2013) ;Giga, Vojislav (55924460200) ;Dobric, Milan (23484928600) ;Beleslin, Branko (6701355424) ;Sobic-Saranovic, Dragana (57202567582) ;Tesic, Milorad (36197477200) ;Djordjevic-Dikic, Ana (57003143600) ;Stepanovic, Jelena (6603897710) ;Nedeljkovic, Ivana (55927577700) ;Artiko, Vera (55887737000) ;Obradovic, Vladimir (7003389726) ;Seferovic, Petar M. (6603594879)Ostojic, Miodrag (34572650500)Background: Patients in chronic phase of myocardial infarction (MI) have decreased coronary flow reserve (CFR) in infarct related artery (IRA) that is proportional to the extent of microvascular/myocardial damage. We proposed a novel model for the assessment of microvascular damage and infarct size using Doppler echocardiography evaluation of CFRs of the IRA (LAD) and reference artery (RCA). Methods: Our study included 34 consecutive patients (28 men, mean age 50 ± 11 years) with first anterior STEMI and single vessel disease successfully treated with primary PCI. All patients underwent SPECT MPI for the assessment of infarct size (expressed as a percentage of myocardium with fixed perfusion abnormalities) and CFR evaluation of LAD and RCA. CFR derived percentage of microvascular damage (CFR PMD) was calculated as: CFR PMD = (CFR RCA - CFR LAD) / (CFR RCA - 1) × 100 (%). Results: CFR PMD correlated significantly with all parameters evaluating the severity of myocardial damage including: peak CK activity (r = 0.632, p < 0.001), WMSI (r = 0.857, p < 0.001), ejection fraction (r = - 0.820, p < 0.001), left ventricular end diastolic (r = 0.757, p < 0.001) and end systolic volume (r = 0.794, p < 0.001). Most importantly, CFR PMD (22 ± 17%) correlated significantly with infarct size by SPECT MPI (21 ± 17%) (r = 0.874, p < 0.001). Conclusions: CFR PMD derived from the proposed model was significantly related to echocardiographic and enzymatic parameters of infarct size, as well as to myocardial damage assessed by SPECT MPI in patients with successfully reperfused first anterior STEMI. © 2012 Elsevier Ireland Ltd. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Evaluation of neuroendocrine tumors with 99mTC-EDDA/HYNIC TOC(2016) ;Artiko, Vera (55887737000) ;Afgan, Aida (57190422396) ;Petrovič, Jelena (57207943674) ;Radovič, Branislava (57189356247) ;Petrovič, Nebojša (7006674561) ;Vlajković, Marina (56190181900) ;Šobić-Šaranovič, Dragana (57202567582)Obradović, Vladimir (7003389726)BACKGROUND: This paper is the short review of our preliminary results obtained with 99mTc-EDDA/HYNIC-TOC. MATERIAL AND METHODS: The total of 495 patients with different neuroendocrine tumors were investigated during last few years. RESULTS: There have been 334 true positive (TP), 73 true negative (TN), 6 false positive (FP) and 82 false negative findings (FN). Diagnosis was made according to SPECT findings in 122 patients (25%). The mean T/NT ratio for TP cases was significantly higher (p < 0.01) on SPECT (3.12 ± 1.13) than on whole body scan (2.2 ± 0.75). According to our results, overall sensitivity of the method is 80%, specificity 92%, positive predictive value 98%, negative predictive value 47% and accuracy 82%. Fifteen TP patients underwent therapy with 90Y-DOTATATE. CONCLUSION: Scintigraphy of neuroendocrine tumors with 99mTc-Tektrotyd is a useful method for diagnosis, staging and follow up of the patients suspected to have neuroendocrine tumors. SPECT had important role in diagnosis. It is also helpful in the appropriate choice of the therapy, including the peptide receptor radionuclide therapy. In the absence of 68Ga-labeled peptides and PET/CT, the special emphasize should be given to application of SPECT/CT as well as to the radioguided surgery. © Copyright 2016 Via Medica. - Some of the metrics are blocked by yourconsent settings
Publication FDG PET-CT as an important diagnostic tool and prognostic marker in suspected recurrent cervical carcinoma after radiotherapy: comparison with MRI(2022) ;Stojiljkovic, Milica (55217486100) ;Saranovic, Dragana Sobic (57234390300) ;Odalovic, Strahinja (57218390032) ;Popovic, Marina (57428070900) ;Petrovic, Jelena (57207943674) ;Rankovic, Nevena (57222052968) ;Veljkovic, Milos (57211281286)Artiko, Vera (55887737000)Background. Recurrent disease in post-irradiation patients with cervical cancer is often difficult to delineate on magnetic resonance imaging (MRI), because posttreatment changes can have a similar appearance, and further evaluation is often required. The aims of the study were to evaluate positron emission tomography/computed tomography with 18F-fluorodeoxyglucose (FDG PET-CT) diagnostic role in suspected recurrent cervical cancer after radiotherapy, compare it to MRI, and assess their prognostic impact in these patients. Patients and methods. This cohort retrospective study included patients previously treated with radiotherapy for carcinoma of uterine cervix with suspected recurrence, who had undergone MRI of abdomen and pelvis, and were subsequently evaluated on FDG PET-CT, with minimum follow-up period of 12 months. Results. In the total of 84 patients included in analysis, MRI vs. FDG PET-CT showed sensitivity, specificity and accuracy of 80.1%, 52.4% and 66.7%, vs. 97.6%, 61.9% and 79.8%, respectively. Patients with positive findings on MRI (Log Rank, p = 0.003) and PET-CT (Log Rank, p < 0.001) had shorter progression-free survival (PFS) than those with negative results. In univariate Cox regression models, MRI and FDG PET-CT results were found to be related to PFS (p = 0.005 and p < 0.001, respectively). However, multivariate analysis proved only FDG PET-CT to be independent prognostic factor, where patients with positive FDG PET-CT results had almost nine times higher risk of progression (p < 0.001). Conclusion. FDG PET-CT represents useful diagnostic tool in suspected recurrent cervical cancer after radiotherapy, showing high sensitivity in its detection. In addition, it is an independent factor in predicting progression-free survival in these patients. © 2022 Sciendo. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication FDG PET/CT in bone sarcoidosis(2016) ;Milojevic, Isidora Grozdic (37107616900) ;Sobic-Saranovic, Dragana (57202567582) ;Videnovic-Ivanov, Jelica (13409677000) ;Vucinic-Mihailovic, Violeta (13410241600) ;Saranovic, Djordjije (57217645313) ;Odalovic, Strahinja (57218390032)Artiko, Vera (55887737000)Background: Bone sarcoidosis is rare manifestation of disease usually accompanied with pulmonary involvement. Until today, exact prevalence of bone sarcoidosis is not known, since reported prevalence varies widely depending on the studied population and the used diagnostic techniques. Objective: To determine the prevalence of bone involvement and distribution pattern in active chronic sarcoidosis by using FDG PET/CT. Methods: Between January 2010 and December 2011, 98 patients with chronic sarcoidosis and presence of prolonged symptoms or other findings suggestive of active disease were referred to FDG PET/CT examination. Active disease was found in 82 patients, and they all were screened for presence of bone sarcoidosis on FDG PET/CT. All patients also underwent MDCT and assessment of serum ACE level. Results: Bone sarcoidosis was present in 18/82 patients with active sarcoidosis. FDG uptake in bones was focal in 8 (44.4%), diffuse in 6 (33.3%) and both diffuse and focal in 4 (22.2%) patients. CT indicated bone abnormalities only in 5% patients. Osseous involvement was present in: pelvis (61.1%), vertebrae (44.4%), ribs (27.8%) and bone marrow (16.7%). Some patients had two or more locations of disease. Follow-up FDG PET/CT showed normal findings in two patients, same localization of active disease in four patients and progression of disease in one. Conclusion: In patients with active chronic sarcoidosis 22% of patients had osseous abnormalities on FDG PET/CT that mostly were not detected on CT. (Sarcoidosis Vasc Diffuse Lung Dis 2016; 33: 66-74). © Mattioli 1885. - Some of the metrics are blocked by yourconsent settings
Publication Gallbladder motility disorders estimated by non-invasive methods(2012) ;Petrović, Milorad (55989504900) ;Radoman, Irena (24399938800) ;Artiko, Vera (55887737000) ;Stojković, Mirjana (57193092735) ;Stojković, Milica (37862065400) ;Durutović, Darija (39361468200) ;Žuvela, Marinko (6602952252) ;Matić, Slavko (7004660212) ;Antić, Andrija (6603457520) ;Palibrk, Ivan (6507415211) ;Milovanović, Aleksandar (57213394853) ;Milovanović, Jovica (6603250148) ;Galun, Danijel (23496063400) ;Radovanović, Nebojša (57221820776) ;Bobić-Radovanović, Anica (6507202652) ;Šobić, Dragana (57202567582)Obradović, Vladimir (7003389726)Background/Aims: The aim is to compare the radionuclide (DC) and ultrasonographic (US) method in the assessment of gallbladder (GB) motility. Methodology: The study was performed in 15 controls (C), 10 patients with acute cholecystitis (AC), 20 patients with chronic acalculous cholecystitis (CAC), 26 patients with chronic cholecystitis with calculosis (CCC) as well as in 15 patients with GB dyskinesia (D). GB emptying period (EP), ejection fraction (EF) and ejection rate (ER) were estimated with dynamic cholescintigraphy (DC) and US. Results: The DC and US finding in the patients with AC was typical in all the patients, i.e. GB was not visualized at all on DC, while on US, stone was visible in the cystic duct. There were significant differences (p<0.05) between the EF and ER values obtained between C and the three groups of patients CAC, CCC and D, using both methods. However, there were no significant differences in EF, EP and ER values among CAC, CCC and D (p>0.05). There was also high correlation between the results obtained with both methods in all the groups of patients studied. Conclusions: The results obtained by both methods are valuable for the assessment of GB motility. Although there are no significant differences and there is a high correlation between the values, radionuclide method is more precise, because it can register motility continuously. © H.G.E. Update Medical Publishing S.A.
- «
- 1 (current)
- 2
- 3
- »
